CARBAMAZEPINE VS PHENYTOIN - CONTROLLED CLINICAL-TRIAL IN FOCAL MOTOR AND GENERALIZED EPILEPSY

被引:42
作者
KOSTELJANETZ, M [1 ]
CHRISTIANSEN, J [1 ]
DAM, AM [1 ]
HANSEN, BS [1 ]
LYON, BB [1 ]
PEDERSEN, H [1 ]
DAM, M [1 ]
机构
[1] HVIDOVRE HOSP, UNIV CLIN NEUROL, DK-2650 HVIDOVRE, DENMARK
关键词
D O I
10.1001/archneur.1979.00500370052010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The antiepileptic effects of carbamazepine and phenytoin were compared in a double-blind crossover trial studying patients with primary and secondary generalized seizures and partial seizures with motor symptoms. Each treatment period lasted ten weeks. The patients were seen every two weeks, and doses were adjusted according to plasma levels. It was attempted to keep levels in the optimal plasma range, ie, 10 to 20 and 4 to 10 mg/liter for phenytoin and carbamazepine, respectively. Twenty-three patients entered and 19 completed the study. No statistically significant differences were found between carbamazepine and phenytoin with regard to seizure control and acute side effects. © 1979, American Medical Association. All rights reserved.
引用
收藏
页码:22 / 24
页数:3
相关论文
共 19 条
[1]   TEGRETOL (CARBAMAZEPINE) - A CONTROLLED TRIAL OF A NEW ANTI-CONVULSANT [J].
BIRD, CAK ;
GRIFFIN, BP ;
MIKLASZE.JM ;
GALBRAIT.AW .
BRITISH JOURNAL OF PSYCHIATRY, 1966, 112 (488) :737-+
[2]  
BONDUELLE M., 1964, REV NEUROL [PARIS], V110, P209
[3]   CARBAMAZEPINE FOR EPILEPSY - CONTROLLED PROSPECTIVE EVALUATION [J].
CEREGHINO, JJ ;
BROCK, JT ;
VANMETER, JC ;
PENRY, JK ;
SMITH, LD ;
WHITE, BG .
NEUROLOGY, 1974, 24 (05) :401-410
[4]  
CHRISTIANSEN J, 1973, METHODS ANAL ANTIEPI
[5]  
DAM M, 1975, ACTA NEUROL SCAND, P33
[6]   2-PERIOD CHANGE-OVER DESIGN AND ITS USE IN CLINICAL TRIALS [J].
GRIZZLE, JE .
BIOMETRICS, 1965, 21 (02) :467-&
[7]  
HVIDBERG E F, 1976, Clinical Pharmacokinetics, V1, P161, DOI 10.2165/00003088-197601030-00001
[8]   USE OF NON-PARAMETRIC METHODS IN STATISTICAL-ANALYSIS OF 2-PERIOD CHANGE-OVER DESIGN [J].
KOCH, GG .
BIOMETRICS, 1972, 28 (02) :577-+
[9]  
KUTT H, 1975, ACTA NEUROL SCAND, P27
[10]   ANTICONVULSANT EFFECT OF DIPHENYLHYDANTOIN RELATIVE TO PLASMA-LEVELS - PROSPECTIVE 3-YEAR STUDY IN AMBULANT PATIENTS WITH GENERALIZED EPILEPTIC SEIZURES [J].
LUND, L .
ARCHIVES OF NEUROLOGY, 1974, 31 (05) :289-294